ClinicalTrials.Veeva

Menu

Catheter Ablation for Atrial Fibrillation in Preserved Ejection Fraction (AFFECT)

U

University Hospital Heidelberg

Status

Completed

Conditions

Atrial Fibrillation

Treatments

Other: Catheter Ablation

Study type

Observational

Funder types

Other

Identifiers

NCT04317911
UKHD-2-520/2015

Details and patient eligibility

About

Atrial fibrillation (AF) displays high prevalence in heart failure with preserved ejection fraction (HF-PEF) and compromises prognosis of affected patients. This study aims to assess catheter ablation (CA) for AF in patients with HF-PEF compared to AF-patients without systolic or diastolic dysfunction. Primary endpoints are freedom from AF and quality of life at 1 year. Furthermore, the study is designed to elucidate mechanistic characteristics distinguishing arrhythmic substrate and predicting AF-recurrence in patients with HF-PEF. For this purpose, left atrial concentrations of biomarkers for inflammation, fibrosis and neurohumoral activation are determined and hemodynamic measurements are performed periprocedurally.

Information on benefit from CA in these patients is necessary for clinical decision making and mechanistic investigations may point to tailored approaches in order to increase therapeutic efficiency.

Enrollment

102 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Left ventricular ejection fraction ≥50%
  • Scheduled for catheter ablation of AF

Exclusion criteria

  • Significant valvular heart disease
  • Coronary artery disease with >70% stenoses or necessary coronary Intervention at time of recruitment
  • Coronary intervention 60 days before recruitment
  • Coronary bypass surgery 90 days before recruitment
  • Cardiomyopathy or cardiac storage disease (e.g. amyloidosis)
  • Reduced left ventricular ejection fraction
  • Pericardiac disease
  • Significant pulmonary hypertension
  • Chronic obstructive pulmonary disease with home-oxygen-therapy, oral steroids, hospitalization due to exacerbations during the last 12 months before recruitment, or suspected severe pulmonary condition based on clinical evaluation
  • Other non-cardiac conditions associated with limited physical capacity (adipositas permagna, severe anemia)
  • Pregnancy
  • Other limitations for adequate performance of stress echocardiography (e.g. orthopedic reasons)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems